Regeneron Pharmaceuticals | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 1.66B 3.15B 2025-03
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 1.57B 405M 2025-06
Astellas Pharma JPY 90.42B 29.86B 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
GlaxoSmithKline GBP 1.89B 221M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
J&J USD 13.63B 8.21B 2025-03
Kyowa Hakko Kirin JPY 14.12B 6.26B 2025-06
Merck USD 6.77B 864M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Pfizer USD 3.04B 259M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
United Therapeutics USD 408.4M 15.1M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06


Regeneron Pharmaceuticals L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.